These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6420441)

  • 21. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic clearance of human follicle-stimulating hormone assessed by radioimmunoassay, immunoradiometric assay, and in vitro Sertoli cell bioassay.
    Urban RJ; Padmanabhan V; Beitins I; Veldhuis JD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):818-23. PubMed ID: 1909706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An inverse relationship exists between seminal plasma inhibin and serum follicle-stimulating hormone in man.
    Scott RS; Burger HG
    J Clin Endocrinol Metab; 1981 Apr; 52(4):796-803. PubMed ID: 6782118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsatile administration of gonadotropin-releasing hormone does not alter the follicle-stimulating hormone (FSH) isoform distribution pattern of pituitary or circulating FSH in nutritionally growth-restricted ovariectomized lambs.
    Hassing JM; Kletter GB; I'Anson H; Wood RI; Beitins IZ; Foster DL; Padmanabhan V
    Endocrinology; 1993 Apr; 132(4):1527-36. PubMed ID: 8462450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seasonal fluctuations in pituitary gland and plasma levels of gonadotropic hormones in Rana.
    Kim JW; Im WB; Choi HH; Ishii S; Kwon HB
    Gen Comp Endocrinol; 1998 Jan; 109(1):13-23. PubMed ID: 9446718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms.
    Burgon PG; Stanton PG; Robertson DM
    Endocrinology; 1996 Nov; 137(11):4827-36. PubMed ID: 8895353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of estrogen-induced discharge of luteinizing hormone in lactating women.
    Baird DT; McNeilly AS; Sawers RS; Sharpe RM
    J Clin Endocrinol Metab; 1979 Oct; 49(4):500-6. PubMed ID: 479342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ
    J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the metabolic clearance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man.
    Pepperell RJ; Kretser DM; Burger HG
    J Clin Invest; 1975 Jul; 56(1):118-26. PubMed ID: 1170215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum bioactive follicle-stimulating hormone concentrations from prepuberty to adulthood: a cross-sectional study.
    Beitins IZ; Padmanabhan V; Kasa-Vubu J; Kletter GB; Sizonenko PC
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1022-7. PubMed ID: 2119389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential sex steroid negative feedback regulation of pulsatile follicle-stimulating hormone secretion in healthy older men: deconvolution analysis and steady-state sex-steroid hormone infusions in frequently sampled healthy older individuals.
    Veldhuis JD; Iranmanesh A; Samojlik E; Urban RJ
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1248-54. PubMed ID: 9100603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement with recombinant human inhibin immediately after orchidectomy in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) maintains follicle-stimulating hormone (FSH) secretion and FSH beta messenger ribonucleic acid levels at precastration values.
    Majumdar SS; Mikuma N; Ishwad PC; Winters SJ; Attardi BJ; Perera AD; Plant TM
    Endocrinology; 1995 May; 136(5):1969-77. PubMed ID: 7720645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in plasma luteinizing hormone-releasing hormone and gonadotropin concentrations during constant rate intravenous infusion of luteinizing hormone-releasing hormone in cyclic rats.
    Blake CA
    Endocrinology; 1978 Apr; 102(4):1043-52. PubMed ID: 369828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
    Tenover JS; Matsumoto AM; Plymate SR; Bremner WJ
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1118-26. PubMed ID: 3119649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women.
    Reame NE; Wyman TL; Phillips DJ; de Kretser DM; Padmanabhan V
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3302-7. PubMed ID: 9745445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary.
    Wide L; Hobson B
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):17-22. PubMed ID: 3094307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypersecretion of follicle-stimulating hormone (FSH) after ovariectomy of hypophysectomized, pituitary-grafted rats: implications for local regulatory control of FSH.
    DePaolo LV
    Endocrinology; 1991 Apr; 128(4):1731-40. PubMed ID: 1900775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.